fluorescein-5-isothiocyanate has been researched along with tetracycline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DeMayo, FJ; Fernandez-Valdivia, R; Lydon, JP; Mukherjee, A; Soyal, SM | 1 |
Chen, J; Kong, J; Li, Q; Ouyang, J; Xing, MM; Zhong, W; Zhou, B | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and tetracycline
Article | Year |
---|---|
Targeting reverse tetracycline-dependent transactivator to murine mammary epithelial cells that express the progesterone receptor.
Topics: Animals; beta-Galactosidase; Doxycycline; Epithelial Cells; Female; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Gene Expression Regulation; Gene Targeting; Immunohistochemistry; Mammary Glands, Animal; Mice; Mice, Transgenic; Microscopy, Fluorescence; Receptors, Progesterone; Tetracycline; Trans-Activators; Transgenes | 2007 |
PLLA-PEG-TCH-labeled bioactive molecule nanofibers for tissue engineering.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Cell Adhesion; Cell Growth Processes; Drug Carriers; Fibroblasts; Fluorescein-5-isothiocyanate; Humans; Lactates; Microbial Sensitivity Tests; Nanofibers; Peptides; Polyethylene Glycols; Rhodamines; Serum Albumin, Bovine; Staphylococcus aureus; Tetracycline; Tissue Engineering; Tissue Scaffolds | 2011 |